CID 71597736

Lasiocepsin-nh2

Structural Information

Molecular Formula
C129H235N39O27S4
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)CN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@@H](NC2=O)CCCCN)CC(C)C)CCCCN)CC(C)C)C(C)C)CCCCN)C(=O)N)CCCCN)CCCCN)CCCCN)CCCCN)C
InChI
InChI=1S/C129H235N39O27S4/c1-17-76(13)103-126(193)146-78(15)106(173)149-83(41-22-30-52-133)111(178)152-84(42-23-31-53-134)112(179)150-80(38-19-27-49-130)108(175)143-65-100(170)147-82(40-21-29-51-132)110(177)161-95-69-197-196-67-93(105(139)172)160-115(182)86(44-25-33-55-136)155-122(189)96(163-125(192)102(75(11)12)164-119(186)91(62-73(7)8)157-114(181)85(43-24-32-54-135)154-117(184)89(60-71(3)4)158-123(190)97-47-36-58-167(97)101(171)66-144-109(176)81(151-121(95)188)39-20-28-50-131)70-199-198-68-94(120(187)145-79(16)107(174)165-103)162-118(185)90(61-72(5)6)159-127(194)104(77(14)18-2)166-116(183)87(45-26-34-56-137)153-113(180)88(46-35-57-142-129(140)141)156-124(191)98-48-37-59-168(98)128(195)92(63-74(9)10)148-99(169)64-138/h71-98,102-104H,17-70,130-138H2,1-16H3,(H2,139,172)(H,143,175)(H,144,176)(H,145,187)(H,146,193)(H,147,170)(H,148,169)(H,149,173)(H,150,179)(H,151,188)(H,152,178)(H,153,180)(H,154,184)(H,155,189)(H,156,191)(H,157,181)(H,158,190)(H,159,194)(H,160,182)(H,161,177)(H,162,185)(H,163,192)(H,164,186)(H,165,174)(H,166,183)(H4,140,141,142)/t76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,102-,103-,104-/m0/s1
InChIKey
BCQRGJNLWMEIEU-QKSXZUPSSA-N
Compound name
(1R,6R,9S,12S,15S,18S,21S,24S,30S,33R,36S,45S,48S,51S,54S,57S,62S,65R)-6-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-18,21,24,30,36,51,62-heptakis(4-aminobutyl)-12-[(2S)-butan-2-yl]-9,15-dimethyl-48,54-bis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,46,49,52,55,58,60,63-nonadecaoxo-57-propan-2-yl-3,4,67,68-tetrathia-8,11,14,17,20,23,26,29,32,35,38,41,47,50,53,56,59,61,64-nonadecazatricyclo[31.26.10.041,45]nonahexacontane-65-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2890.7097 Da
Monoisotopic Mass

-2.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2891.7170 253.2
[M+Na]+ 2913.6989 249.5
[M-H]- 2889.7024 251.6
[M+NH4]+ 2908.7435 248.8
[M+K]+ 2929.6729 244.3
[M+H-H2O]+ 2873.7070 235.0
[M+HCOO]- 2935.7079 248.6
[M+CH3COO]- 2949.7236 249.7
[M+Na-2H]- 2911.6844 274.8
[M]+ 2890.7092 226.7
[M]- 2890.7102 226.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.